PIRCISLY

Welcome to the Brand page for “PIRCISLY”, which is offered here for Pharmaceutical preparations used for the treatment of gastrointestinal disorders and diseases, colitis, crohn's disease, inflammatory bowel disease, systemic sclerosis, interstitial lung disease, systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer; diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use;disease management services; medical services, providing medical information to health care providers, managed care providers and patients via computer networks; providing health information in the field of gastrointestinal diseases, colitis, crohn's disease, inflammatory bowel disease, systemic sclerosis, interstitial lung disease, systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; providing information relating to medical diagnostic testing; providing information relating to treatment recommendation; medical consultation; providing a website featuring information about services for the diagnosis, prevention, and treatment of gastrointestinal disorders and diseases, colitis, crohn's disease, inflammatory bowel disease, systemic sclerosis, interstitial lung disease, systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer;medical laboratory services, laboratory testing, medical diagnostic testing, evaluation, and medical research services; medical laboratory services, laboratory testing in the field of disease management and pathology and of patient diagnosis and patient selection;.

Its status is currently believed to be active. Its class is unavailable. “PIRCISLY” is believed to be currently owned by “PROMETHEUS BIOSCIENCES, INC.”